U.S. markets open in 4 hours 32 minutes

Freeline Therapeutics Holdings plc (FRLN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9684-0.0316 (-3.16%)
At close: 04:00PM EDT
0.9998 +0.03 (+3.24%)
After hours: 07:30PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.0000
Bid0.0000 x 800
Ask0.0000 x 1000
Day's Range0.9001 - 1.0500
52 Week Range0.6500 - 15.4000
Avg. Volume125,830
Market Cap62.682M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for FRLN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Freeline Therapeutics Holdings
    Daily – Vickers Top Buyers & Sellers for 05/19/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more

    2 Net Current Asset Value Stocks to Consider

    Short-term investors could be interested in these businesses


    Federated Hermes Prudent Bear Fund Buys PowerShares QQQ Trust Ser 1, iShares Russell 2000 ETF, ...

    Investment company Federated Hermes Prudent Bear Fund (Current Portfolio) buys PowerShares QQQ Trust Ser 1, iShares Russell 2000 ETF, iShares MSCI Emerging Markets ETF, SPDR Biotech ETF, iShares MSCI EAFE ETF, sells S&P 500 ETF TRUST ETF, Financial Select Sector SPDR, Health Care Select Sector SPDR, ARK Genomic Revolution ETF, Cisco Systems Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Federated Hermes Prudent Bear Fund.

  • Benzinga

    Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program

    Freeline Therapeutics Holdings plc (NASDAQ: FRLN) gave an update on its investigational Fabry disease treatment FLT190, currently in a Phase 1/2 trial, saying the candidate proved durable in the second patient tested. Fabry disease is an inherited metabolic disorder resulting from the absent or markedly deficient activity of lysosomal enzyme α-galactosidase A, or α-Gal A. Patient Two was dosed at the lowest dose cohort of 7.5e11 vg/kg and experienced a sustained and durable response with an incr